U.S., Nov. 7 -- ClinicalTrials.gov registry received information related to the study (NCT07923058) titled 'Clinical Trial of SEEG for Drug-resistant Epilepsy' on Oct. 21.

Brief Summary: This trial evaluates the safety and efficacy of SEEG recording and functional mapping for patients with drug-resistant epilepsy. It also assesses the safety and therapeutic effectiveness of SEEG-guided radiofrequency ablation for this patient group. The study will collect clinical evidence to support the standardized application of this combined diagnostic and treatment workflow for drug-resistant epilepsy.

Study Start Date: Oct. 23

Study Type: INTERVENTIONAL

Condition: Drug-Resistant Epilepsy

Intervention: PROCEDURE: SEEG RF-TC

The patient will und...